{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:52:10Z","timestamp":1763967130282,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Acne has several effects on physical symptoms, but the main impacts are on the quality of life, which can be improved by treatment. There are several acne treatments but less evidence comparing their relative efficacy. Thus, we assessed the comparative efficacy of pharmacological and nonpharmacological interventions for acne. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials from inception to April 2019, to include randomized controlled trials for acne that compared topical antibiotics (TA), benzoyl peroxide (BPO), topical retinoids (TR), oral antibiotics (OA), lasers, light devices including LED device (LED), photodynamic therapy (PDT), and intense pulsed light, chemical peels (CP), miscellaneous therapies or complementary and alternative medicine (MTCAM), or their combinations. We performed Bayesian network meta-analysis with random effects for all treatments compared with placebo and each other. Mean differences (MDs) of lesions count and risk ratios of adverse events with their 95% credible intervals (CrIs) were calculated, and all interventions were ranked by the Surface Under the Cumulative Ranking (SUCRA) values. Additional frequentist additive network meta-analysis was performed to detect the robustness of results and potential interaction effects. Sensitivity analyses were carried out with different priors, and metaregression was to adjust for nine potential effect modifiers. In the result, seventy-three randomized controlled trials (27,745 patients with mild to moderate acne), comparing 30 grouped intervention categories, were included with low to moderate risk of bias. For adverse effects, OA had more risk in combination treatment with others. For noninflammatory lesions reduction, seventeen interventions had significant differences comparing with placebo and three interventions (TR+BPO: MD = \u221221.89, 95%CrI [\u221228.97, \u221214.76]; TR+BPO+MTCAM: \u221222.48 [\u221234.13, \u221210.70]; TA+BPO+CP: \u221220.63 [\u221233.97, \u22127.13]) were superior to others with 94, 94, and 91% SUCRA values, respectively. For inflammatory lesions reduction, nineteen interventions were significantly better than placebo, and three interventions (TR+BPO: MD = \u221212.13, 95%CrI [\u221218.41, \u22125.80]; TR+BPO+MTCAM: \u221213.21 [\u2212.39, \u22123.04]; LED: \u221211.30 [\u221218.34, \u22124.42]) were superior to others (SUCRA: 81, 81, and 77%, respectively). In summary of noninflammatory and inflammatory lesions results, TR+BPO and TA+BPO were the best options compared to others. The frequentist model showed similar results as above. In summary, current evidence supports the suggestion that TR+BPO and TA+BPO are the best options for mild to moderate acne. LED is another option for inflammatory lesions when drug resistance occurs. All the combinations involved with OA showed more risk of adverse events than others. However, the evidence of this study should be cautiously used due to the limitations.<\/jats:p>","DOI":"10.3389\/fphar.2020.592075","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:33:08Z","timestamp":1606368788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Efficacy of Pharmacological and Nonpharmacological Interventions for Acne Vulgaris: A Network Meta-Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Qingyang","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/09546634.2010.488260","article-title":"Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial","volume":"23","author":"Afzali","year":"2012","journal-title":"J. Dermatol. Treat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14764172.2016.1247961","article-title":"Clinical comparison of salicylic acid peel and LED-Laser phototherapy for the treatment of Acne vulgaris in teenagers","volume":"19","author":"Alba","year":"2017","journal-title":"J. Cosmet. Laser Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1503\/cmaj.140665","article-title":"Management of acne: Canadian clinical practice guideline","volume":"188","author":"Asai","year":"2016","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/pgmj.2006.045377","article-title":"Acne: more than skin deep","volume":"82","author":"Ayer","year":"2006","journal-title":"Postgrad. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2016.08.053","article-title":"Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: a Phase IIa, multicenter, randomized, vehicle-controlled study","volume":"76","author":"Bissonnette","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1994.tb02929.x","article-title":"Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc","volume":"130","author":"Bojar","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for Monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J. Comput. Graph Stat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD009436","DOI":"10.1002\/14651858.CD009436.pub2","article-title":"Complementary therapies for acne vulgaris","volume":"1","author":"Cao","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"B12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1365-2133.2007.08083.x","article-title":"Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris","volume":"157","author":"Charakida","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e019607","DOI":"10.1136\/bmjopen-2017-019607","article-title":"Chemical peels for acne vulgaris: a systematic review of randomised controlled trials","volume":"8","author":"Chen","year":"2018","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0272989X13485157","article-title":"Evidence synthesis for decision making 3: heterogeneity\u2014Subgroups, meta-regression, bias, and bias-Adjustment","volume":"33","author":"Dias","year":"2013","journal-title":"Med. Decis. Making"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","volume":"7","author":"Gelman","year":"1992","journal-title":"Stat. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jdv.13191","article-title":"Acne and quality of life\u2014impact and management","volume":"29","author":"Gieler","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J. Invest. Dermatol."},{"volume-title":"Cochrane handbook for systematic reviews of interventions Version 5.1.0 (updated March 2011)","year":"2011","author":"Higgins","key":"B19"},{"key":"B20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis","volume":"76","author":"Huang","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews Incorporating network meta-analyses of Health care interventions: Checklist and Explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1056\/NEJMcp033487","article-title":"Clinical practice","volume":"352","author":"James","year":"2005","journal-title":"Acne. N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality: an update from the global burden of disease study 2013","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.1987.tb05853.x","article-title":"Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris","volume":"116","author":"Katsambas","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1346-8138.2010.00855.x","article-title":"Community-based epidemiological study of psychosocial effects of acne in Japanese adolescents","volume":"37","author":"Kubota","year":"2010","journal-title":"J. Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1365-2230.2009.03340.x","article-title":"Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong","volume":"35","author":"Law","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/ijd.13631","article-title":"Randomized, controlled trial split-faced study of 595-nm pulsed dye laser in the treatment of acne vulgaris and acne erythema in adolescents and early adulthood","volume":"56","author":"Lekwuttikarn","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021549","article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015354","article-title":"The prevalence of acne in Mainland China: a systematic review and meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/1389200216666150812124801","article-title":"Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris","volume":"16","author":"Liu","year":"2015","journal-title":"Curr. Drug Metabol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40257-019-00438-6","article-title":"Quality-of-Life research in acne vulgaris: current status and future directions","volume":"20","author":"Marron","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting Items for systematic reviews and meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/DSS.0000000000000167","article-title":"Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris--an image analysis evaluation","volume":"40","author":"Moneib","year":"2014","journal-title":"Dermatol. Surg."},{"key":"B35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2230.2000.00562.x","article-title":"Chloroxylenol and zinc oxide containing cream (Nels cream) vs. 5% benzoyl peroxide cream in the treatment of acne vulgaris. A double-blind, randomized, controlled trial","volume":"25","author":"Papageorgiou","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bimj.201800167","article-title":"Network meta-analysis of multicomponent interventions","volume":"62","author":"R\u00fccker","year":"2019","journal-title":"Biom. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bmj.298.6682.1217","article-title":"Acne in schoolchildren: no longer a concern for dermatologists","volume":"298","author":"Rademaker","year":"1989","journal-title":"BMJ"},{"key":"B40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"J. Clin. Epidemiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B42","unstructured":"Official Git repository of R package netmeta. Contribute to guido-s\/netmeta development by creating an account on GitHub\n            SchwarzerG\n          2019"},{"key":"B43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2009.07.052","article-title":"Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide\/clindamycin in acne","volume":"63","author":"Seidler","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.jaad.2011.03.014","article-title":"Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne","volume":"65","author":"Seidler","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the global Alliance to Improve outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"B46","unstructured":"GeMTC R package: model generation for network meta-analysis: gertvv\/gemtc\n            ValkenhoefG. van\n          2018"},{"key":"B47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res. Synth. Methods"},{"key":"B48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res. Synth. Methods"},{"key":"B49","unstructured":"Metafor: meta-Analysis package for R\n            ViechtbauerW.\n          2019"},{"key":"B50","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0190-9622(98)70442-6","article-title":"Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris","volume":"39","author":"White","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/jdv.14475","article-title":"Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents\/young adults in 7 European countries","volume":"32","author":"Wolkenstein","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-4632.2009.03922.x","article-title":"Acne vulgaris in Nigerian adolescents\u2014prevalence, severity, beliefs, perceptions, and practices","volume":"48","author":"Yahya","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.592075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T10:56:22Z","timestamp":1606474582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.592075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":54,"alternative-id":["10.3389\/fphar.2020.592075"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.592075","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"592075"}}